Educación médica continua para profesionales de la salud
Mantenerse actualizado con los últimos avances en la salud del cáncer es esencial para los profesionales de la salud. Nuestros recursos de Educación Médica Continua (CME) ofrecen información detallada sobre el panorama cambiante de la oncología. Explore una variedad de materiales educativos diseñados para capacitar a los profesionales médicos con el conocimiento necesario para ofrecer la mejor atención posible a los pacientes que padecen cáncer. Manténgase informado sobre los últimos enfoques de tratamiento, resultados de investigaciones y terapias innovadoras.
Patrocinado por
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck.
Collected specimens will be used in laboratory studie ...
Condición: Head and Neck Cancers
The Sexual Health of Rectal Cancer Patients
We know that treatment for rectal, colorectal or anal cancer can impact sexual function.
This study aims to learn:
- How the treatment affects emotional and social well-being.
-
Condición: Rectal Cancer
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
The purpose of this study is to find out whether a protein, called mesothelin, found in the blood and tissue can be used as "marker" for esophageal cancer.
Doctors at Memorial Sloan-Ket ...
Condición: Esophageal Cancer
The immunological and prognostic significance of the diabetes mellitus-related gene WFS1 in endometrial cancer
Background: Diabetes is associated with the incidence and prognosis of various malignancies, most notably endometrial cancer (EC). This study investigated the connection between diabetes and EC, with
Development of pituitary dysfunction and destructive thyroiditis is associated with better survival in non-small cell lung cancer patients treated with programmed cell death-1 inhibitors: a prospective study with immortal time bias correction
Background: Immune-related adverse events (irAEs) are reported to be associated with better overall survival (OS) in non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibito
How nuclear medicine helps cancer patients | Tomorrow's Cure Episode 4
Nuclear medicine therapy is sometimes the best option for people who no longer respond to other treatments. It is often helpful for ...
Nuclear medicine giving hope to cancer patients | 9 News Australia
A crucial cancer treatment has emerged from the atomic research facility in Sydney that locates cancer cells and hits them with ...
Improving Surgical Outcomes for Patients with Colorectal Cancer
Rocco Ricciardi, MD, MPH, is chief of the Section of Colon and Rectal Surgery at Massachusetts General Hospital. In this video ...